Guney Eskiler, Gamze; Yanar, Sevinc; Akpinar, Gurler; Kasap, Murat
(WILEY, 2021)
Talazoparib (TAL) has been effectively used for the treatment of gBRCA1/2-mutated HER2-negative metastatic breast cancer. However, acquired resistance to TAL remains a major challenge that impedes the clinical success of ...